ScienceDaily (Sep. 2, 2009) — A research report featured on the cover of the September 2009 print issue of The FASEB Journal describes how Australian scientists developed a new gene therapy vector that uses the same machinery that viruses use to transport their cargo into our cells. As a result of this achievement, therapeutic DNA can be transferred to a cell's nucleus far more efficiently than in the past, raising hopes for more effective treatment of genetic disorders and some types of cancers.

"Through the use of proteins that mimic key functions of viruses for the packaging and transport of therapeutic DNA, we hope to improve the efficiency, and above all, the specificity of human gene therapy," said David Jans, from the Nuclear Signaling Laboratory at Monash University in Victoria, Australia and one of the researchers involved in the work. "Following the creation of efficient, specific and safe DNA delivery vectors, the challenges in human gene therapy will be able to move on from questions of delivery to actual clinical application."

In short, a gene therapy vector is used to deliver a therapeutic gene or a portion of DNA into a cell nucleus similar to how a syringe is used to inject medicines. To create the new gene therapy vector, Jans and colleagues used pieces of different genes to create a protein called a "modular DNA carrier," which can be produced by bacteria. This protein carries therapeutic DNA and delivers it to a cell's nucleus, where it reprograms a cell to function properly. In the laboratory, these carrier proteins were combined with therapeutic DNA and attached to cell membrane receptors and the nuclear import machinery of target cells. In turn, the packaged DNA moved into the cell through the cytoplasm and into the nucleus.

"Effective gene therapy is clearly the best way to treat heritable diseases. It's also an approach to other diseases where the environment or infection messes up our genes." said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "The Australians have worked out how viruses identify our nuclear ZIP-code, and have delivered therapeutic genes to the same address. This work opens up a new era of pharmaceutical development."

Story Source:

Adapted from materials provided by Federation of American Societies for Experimental Biology, via EurekAlert!, a service of AAAS.

Journal Reference:

1. Dominic J. Glover, Su May Ng, Adam Mechler, Lisandra L. Martin, and David A. Jans. Multifunctional protein nanocarriers for targeted nuclear gene delivery in nondividing cells. The FASEB Journal, 2009; 23 (9): 2996 DOI: 10.1096/fj.09-131425

Related Stories

Self-Assembled Viruses Efficiently Carry Genes And Drug Molecules Into Tumor Cells (June 2, 2008) — Korean researchers have made an artificial virus, which they have been able to use to transport both genes and drugs into the interior of cancer ...  > read more

First Large-Scale Computer Simulation Of Gene Therapy (Apr. 30, 2009) — Scientists have completed the first comprehensive, molecular-level numerical study of gene therapy. Their work should help other scientists design new experimental gene therapies and possibly solve ...  > read more

Development Of New Polymer Delivery Vehicles For Gene Therapy (Oct. 17, 2006) — MIT scientists are reporting synthesis and laboratory tests of a promising new group of degradable polymer delivery vehicles for gene therapy. The polymers are improved versions of materials first ...  > read more

Moving Gene Therapy Forward With Mobile DNA (May 9, 2009) — Researchers have developed a new non-viral gene technology approach. This approach overcomes side-effects associated with the current viral vectors, such as inflammation or the development of cancer. ...  > read more

Search ScienceDaily

Identical Twins Identical Problems